nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CYP2E1—Dacarbazine—muscle cancer	0.128	0.164	CbGbCtD
Pimozide—CYP1A2—Dacarbazine—muscle cancer	0.0739	0.0946	CbGbCtD
Pimozide—CYP3A7—Vincristine—muscle cancer	0.0707	0.0905	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0707	0.0905	CbGbCtD
Pimozide—CYP2E1—Etoposide—muscle cancer	0.0625	0.0801	CbGbCtD
Pimozide—ABCB1—Dactinomycin—muscle cancer	0.056	0.0718	CbGbCtD
Pimozide—CYP3A5—Vincristine—muscle cancer	0.053	0.0679	CbGbCtD
Pimozide—CYP3A5—Etoposide—muscle cancer	0.0486	0.0622	CbGbCtD
Pimozide—CYP1A2—Etoposide—muscle cancer	0.0362	0.0463	CbGbCtD
Pimozide—ABCB1—Vincristine—muscle cancer	0.0345	0.0442	CbGbCtD
Pimozide—ABCB1—Etoposide—muscle cancer	0.0316	0.0405	CbGbCtD
Pimozide—ABCB1—Doxorubicin—muscle cancer	0.0216	0.0276	CbGbCtD
Pimozide—ABCB1—Methotrexate—muscle cancer	0.0209	0.0268	CbGbCtD
Pimozide—CYP3A4—Vincristine—muscle cancer	0.0207	0.0265	CbGbCtD
Pimozide—CYP2D6—Doxorubicin—muscle cancer	0.0203	0.026	CbGbCtD
Pimozide—CYP3A4—Etoposide—muscle cancer	0.0189	0.0243	CbGbCtD
Pimozide—CYP3A4—Doxorubicin—muscle cancer	0.0129	0.0165	CbGbCtD
Pimozide—HTR2A—hindlimb—muscle cancer	0.00268	0.0482	CbGeAlD
Pimozide—HTR2A—appendage—muscle cancer	0.0023	0.0413	CbGeAlD
Pimozide—CACNA1G—head—muscle cancer	0.00194	0.035	CbGeAlD
Pimozide—DRD3—head—muscle cancer	0.00139	0.0249	CbGeAlD
Pimozide—HTR6—head—muscle cancer	0.00133	0.024	CbGeAlD
Pimozide—CALM3—smooth muscle tissue—muscle cancer	0.00126	0.0227	CbGeAlD
Pimozide—CALM2—embryo—muscle cancer	0.00126	0.0226	CbGeAlD
Pimozide—CALM1—embryo—muscle cancer	0.00125	0.0225	CbGeAlD
Pimozide—OPRK1—head—muscle cancer	0.00124	0.0222	CbGeAlD
Pimozide—Loss of libido—Methotrexate—muscle cancer	0.0011	0.019	CcSEcCtD
Pimozide—Aplastic anaemia—Dactinomycin—muscle cancer	0.0011	0.019	CcSEcCtD
Pimozide—CALM3—cardiac atrium—muscle cancer	0.00109	0.0195	CbGeAlD
Pimozide—CALM2—smooth muscle tissue—muscle cancer	0.00099	0.0178	CbGeAlD
Pimozide—CALM1—smooth muscle tissue—muscle cancer	0.000985	0.0177	CbGeAlD
Pimozide—Nuchal rigidity—Methotrexate—muscle cancer	0.000978	0.0169	CcSEcCtD
Pimozide—HTR1A—renal system—muscle cancer	0.00097	0.0174	CbGeAlD
Pimozide—CALM2—renal system—muscle cancer	0.000953	0.0171	CbGeAlD
Pimozide—CALM1—renal system—muscle cancer	0.000949	0.0171	CbGeAlD
Pimozide—CALM3—tendon—muscle cancer	0.000947	0.017	CbGeAlD
Pimozide—CALM3—bone marrow—muscle cancer	0.000918	0.0165	CbGeAlD
Pimozide—CALM3—vagina—muscle cancer	0.000879	0.0158	CbGeAlD
Pimozide—OPRM1—head—muscle cancer	0.000879	0.0158	CbGeAlD
Pimozide—KCNH2—renal system—muscle cancer	0.000863	0.0155	CbGeAlD
Pimozide—CALM2—cardiac atrium—muscle cancer	0.000853	0.0153	CbGeAlD
Pimozide—CALM1—cardiac atrium—muscle cancer	0.00085	0.0153	CbGeAlD
Pimozide—OPRM1—testis—muscle cancer	0.000849	0.0153	CbGeAlD
Pimozide—CHRM2—head—muscle cancer	0.0008	0.0144	CbGeAlD
Pimozide—CALM3—testis—muscle cancer	0.000784	0.0141	CbGeAlD
Pimozide—Body temperature decreased—Doxorubicin—muscle cancer	0.000783	0.0136	CcSEcCtD
Pimozide—Hypothermia—Doxorubicin—muscle cancer	0.000783	0.0136	CcSEcCtD
Pimozide—KCNH2—cardiac atrium—muscle cancer	0.000773	0.0139	CbGeAlD
Pimozide—HTR2A—embryo—muscle cancer	0.000763	0.0137	CbGeAlD
Pimozide—Hyponatraemia—Vincristine—muscle cancer	0.000762	0.0132	CcSEcCtD
Pimozide—CALM2—tendon—muscle cancer	0.000744	0.0134	CbGeAlD
Pimozide—CALM1—tendon—muscle cancer	0.00074	0.0133	CbGeAlD
Pimozide—CYP1A2—renal system—muscle cancer	0.000739	0.0133	CbGeAlD
Pimozide—Dysphagia—Dactinomycin—muscle cancer	0.000734	0.0127	CcSEcCtD
Pimozide—Urinary retention—Vincristine—muscle cancer	0.000721	0.0125	CcSEcCtD
Pimozide—CALM2—bone marrow—muscle cancer	0.000721	0.013	CbGeAlD
Pimozide—HRH1—smooth muscle tissue—muscle cancer	0.000719	0.0129	CbGeAlD
Pimozide—CALM1—bone marrow—muscle cancer	0.000717	0.0129	CbGeAlD
Pimozide—CYP3A5—renal system—muscle cancer	0.000713	0.0128	CbGeAlD
Pimozide—Pancytopenia—Dactinomycin—muscle cancer	0.000697	0.0121	CcSEcCtD
Pimozide—CALM2—vagina—muscle cancer	0.00069	0.0124	CbGeAlD
Pimozide—CALM1—vagina—muscle cancer	0.000687	0.0124	CbGeAlD
Pimozide—CYP2E1—renal system—muscle cancer	0.000665	0.012	CbGeAlD
Pimozide—CYP2C19—vagina—muscle cancer	0.000655	0.0118	CbGeAlD
Pimozide—KCNH2—bone marrow—muscle cancer	0.000653	0.0117	CbGeAlD
Pimozide—HTR1A—head—muscle cancer	0.000649	0.0117	CbGeAlD
Pimozide—CALM2—head—muscle cancer	0.000638	0.0115	CbGeAlD
Pimozide—CALM1—head—muscle cancer	0.000635	0.0114	CbGeAlD
Pimozide—KCNH2—vagina—muscle cancer	0.000625	0.0112	CbGeAlD
Pimozide—Pancytopenia—Vincristine—muscle cancer	0.000623	0.0108	CcSEcCtD
Pimozide—CALM2—testis—muscle cancer	0.000616	0.0111	CbGeAlD
Pimozide—CALM1—testis—muscle cancer	0.000613	0.011	CbGeAlD
Pimozide—Agranulocytosis—Dactinomycin—muscle cancer	0.000611	0.0106	CcSEcCtD
Pimozide—Erectile dysfunction—Vincristine—muscle cancer	0.000604	0.0105	CcSEcCtD
Pimozide—HTR2A—smooth muscle tissue—muscle cancer	0.0006	0.0108	CbGeAlD
Pimozide—Weight decreased—Vincristine—muscle cancer	0.000593	0.0103	CcSEcCtD
Pimozide—Speech disorder—Methotrexate—muscle cancer	0.00059	0.0102	CcSEcCtD
Pimozide—DRD2—head—muscle cancer	0.000586	0.0105	CbGeAlD
Pimozide—Depression—Vincristine—muscle cancer	0.000583	0.0101	CcSEcCtD
Pimozide—HTR2A—renal system—muscle cancer	0.000578	0.0104	CbGeAlD
Pimozide—KCNH2—head—muscle cancer	0.000578	0.0104	CbGeAlD
Pimozide—DRD2—testis—muscle cancer	0.000566	0.0102	CbGeAlD
Pimozide—Sweating—Vincristine—muscle cancer	0.000561	0.00972	CcSEcCtD
Pimozide—KCNH2—testis—muscle cancer	0.000558	0.01	CbGeAlD
Pimozide—Cramp muscle—Etoposide—muscle cancer	0.000553	0.00959	CcSEcCtD
Pimozide—HRH1—tendon—muscle cancer	0.00054	0.00971	CbGeAlD
Pimozide—CYP3A4—renal system—muscle cancer	0.000535	0.00962	CbGeAlD
Pimozide—Dysphagia—Etoposide—muscle cancer	0.000531	0.00921	CcSEcCtD
Pimozide—CYP2D6—renal system—muscle cancer	0.000526	0.00947	CbGeAlD
Pimozide—Blood disorder—Doxorubicin—muscle cancer	0.000526	0.00911	CcSEcCtD
Pimozide—CYP2E1—tendon—muscle cancer	0.000519	0.00933	CbGeAlD
Pimozide—CYP3A5—vagina—muscle cancer	0.000516	0.00928	CbGeAlD
Pimozide—Connective tissue disorder—Vincristine—muscle cancer	0.000516	0.00894	CcSEcCtD
Pimozide—Pancytopenia—Etoposide—muscle cancer	0.000504	0.00875	CcSEcCtD
Pimozide—HRH1—vagina—muscle cancer	0.000501	0.00901	CbGeAlD
Pimozide—ABCB1—embryo—muscle cancer	0.0005	0.009	CbGeAlD
Pimozide—Amenorrhoea—Doxorubicin—muscle cancer	0.0005	0.00866	CcSEcCtD
Pimozide—Cardiac disorder—Vincristine—muscle cancer	0.000487	0.00844	CcSEcCtD
Pimozide—Aplastic anaemia—Methotrexate—muscle cancer	0.000476	0.00825	CcSEcCtD
Pimozide—Nocturia—Doxorubicin—muscle cancer	0.000473	0.00821	CcSEcCtD
Pimozide—Anaemia—Dactinomycin—muscle cancer	0.000473	0.00819	CcSEcCtD
Pimozide—Dyskinesia—Doxorubicin—muscle cancer	0.000467	0.0081	CcSEcCtD
Pimozide—HRH1—head—muscle cancer	0.000463	0.00832	CbGeAlD
Pimozide—Mental disorder—Vincristine—muscle cancer	0.00046	0.00797	CcSEcCtD
Pimozide—Leukopenia—Dactinomycin—muscle cancer	0.000458	0.00794	CcSEcCtD
Pimozide—Gynaecomastia—Methotrexate—muscle cancer	0.000454	0.00787	CcSEcCtD
Pimozide—HTR2A—tendon—muscle cancer	0.000451	0.00811	CbGeAlD
Pimozide—HRH1—testis—muscle cancer	0.000447	0.00804	CbGeAlD
Pimozide—CYP2E1—head—muscle cancer	0.000445	0.008	CbGeAlD
Pimozide—Agranulocytosis—Etoposide—muscle cancer	0.000442	0.00766	CcSEcCtD
Pimozide—Ventricular tachycardia—Doxorubicin—muscle cancer	0.000439	0.00761	CcSEcCtD
Pimozide—Myalgia—Dactinomycin—muscle cancer	0.000435	0.00755	CcSEcCtD
Pimozide—Abnormal dreams—Doxorubicin—muscle cancer	0.000434	0.00752	CcSEcCtD
Pimozide—Eructation—Doxorubicin—muscle cancer	0.000431	0.00748	CcSEcCtD
Pimozide—CYP2E1—testis—muscle cancer	0.00043	0.00773	CbGeAlD
Pimozide—Salivary hypersecretion—Doxorubicin—muscle cancer	0.000426	0.00739	CcSEcCtD
Pimozide—Anaemia—Vincristine—muscle cancer	0.000422	0.00732	CcSEcCtD
Pimozide—Agitation—Vincristine—muscle cancer	0.00042	0.00728	CcSEcCtD
Pimozide—HTR2A—vagina—muscle cancer	0.000419	0.00753	CbGeAlD
Pimozide—Aplastic anaemia—Doxorubicin—muscle cancer	0.000412	0.00715	CcSEcCtD
Pimozide—Leukopenia—Vincristine—muscle cancer	0.000409	0.00709	CcSEcCtD
Pimozide—Anorexia—Dactinomycin—muscle cancer	0.000398	0.0069	CcSEcCtD
Pimozide—Eye disorder—Etoposide—muscle cancer	0.000397	0.00689	CcSEcCtD
Pimozide—Convulsion—Vincristine—muscle cancer	0.000396	0.00686	CcSEcCtD
Pimozide—Cardiac disorder—Etoposide—muscle cancer	0.000395	0.00684	CcSEcCtD
Pimozide—Hypertension—Vincristine—muscle cancer	0.000394	0.00684	CcSEcCtD
Pimozide—Myalgia—Vincristine—muscle cancer	0.000389	0.00674	CcSEcCtD
Pimozide—Visual disturbance—Methotrexate—muscle cancer	0.000388	0.00673	CcSEcCtD
Pimozide—HTR2A—head—muscle cancer	0.000387	0.00695	CbGeAlD
Pimozide—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00038	0.00659	CcSEcCtD
Pimozide—ABCB1—renal system—muscle cancer	0.000379	0.00681	CbGeAlD
Pimozide—HTR2A—testis—muscle cancer	0.000373	0.00672	CbGeAlD
Pimozide—Nervous system disorder—Vincristine—muscle cancer	0.000366	0.00634	CcSEcCtD
Pimozide—Decreased appetite—Dactinomycin—muscle cancer	0.000363	0.00629	CcSEcCtD
Pimozide—Hyperhidrosis—Vincristine—muscle cancer	0.00036	0.00625	CcSEcCtD
Pimozide—Muscle spasms—Etoposide—muscle cancer	0.000356	0.00617	CcSEcCtD
Pimozide—Anorexia—Vincristine—muscle cancer	0.000355	0.00616	CcSEcCtD
Pimozide—CYP2D6—head—muscle cancer	0.000352	0.00633	CbGeAlD
Pimozide—Hypotension—Vincristine—muscle cancer	0.000348	0.00604	CcSEcCtD
Pimozide—Anaemia—Etoposide—muscle cancer	0.000342	0.00593	CcSEcCtD
Pimozide—CYP2D6—testis—muscle cancer	0.00034	0.00612	CbGeAlD
Pimozide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00034	0.00589	CcSEcCtD
Pimozide—Increased appetite—Doxorubicin—muscle cancer	0.000339	0.00588	CcSEcCtD
Pimozide—Insomnia—Vincristine—muscle cancer	0.000337	0.00585	CcSEcCtD
Pimozide—Breast disorder—Methotrexate—muscle cancer	0.000333	0.00577	CcSEcCtD
Pimozide—Leukopenia—Etoposide—muscle cancer	0.000331	0.00574	CcSEcCtD
Pimozide—Loss of consciousness—Etoposide—muscle cancer	0.000325	0.00564	CcSEcCtD
Pimozide—Decreased appetite—Vincristine—muscle cancer	0.000324	0.00562	CcSEcCtD
Pimozide—Gastrointestinal disorder—Vincristine—muscle cancer	0.000322	0.00558	CcSEcCtD
Pimozide—Convulsion—Etoposide—muscle cancer	0.000321	0.00556	CcSEcCtD
Pimozide—Hyponatraemia—Doxorubicin—muscle cancer	0.00032	0.00555	CcSEcCtD
Pimozide—Hypertension—Etoposide—muscle cancer	0.00032	0.00554	CcSEcCtD
Pimozide—Constipation—Vincristine—muscle cancer	0.000319	0.00553	CcSEcCtD
Pimozide—Chest pain—Etoposide—muscle cancer	0.000315	0.00546	CcSEcCtD
Pimozide—Eosinophilia—Methotrexate—muscle cancer	0.000315	0.00546	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000313	0.00543	CcSEcCtD
Pimozide—Abdominal discomfort—Methotrexate—muscle cancer	0.000305	0.00529	CcSEcCtD
Pimozide—Pancytopenia—Methotrexate—muscle cancer	0.000302	0.00524	CcSEcCtD
Pimozide—Asthenia—Dactinomycin—muscle cancer	0.000299	0.00519	CcSEcCtD
Pimozide—Tachycardia—Etoposide—muscle cancer	0.000295	0.00511	CcSEcCtD
Pimozide—Skin disorder—Etoposide—muscle cancer	0.000293	0.00509	CcSEcCtD
Pimozide—Erectile dysfunction—Methotrexate—muscle cancer	0.000293	0.00508	CcSEcCtD
Pimozide—Hyperhidrosis—Etoposide—muscle cancer	0.000292	0.00506	CcSEcCtD
Pimozide—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000291	0.00505	CcSEcCtD
Pimozide—Breast disorder—Doxorubicin—muscle cancer	0.000288	0.00499	CcSEcCtD
Pimozide—Anorexia—Etoposide—muscle cancer	0.000288	0.00499	CcSEcCtD
Pimozide—ABCB1—bone marrow—muscle cancer	0.000286	0.00515	CbGeAlD
Pimozide—Diarrhoea—Dactinomycin—muscle cancer	0.000286	0.00495	CcSEcCtD
Pimozide—Drowsiness—Methotrexate—muscle cancer	0.000284	0.00492	CcSEcCtD
Pimozide—Depression—Methotrexate—muscle cancer	0.000283	0.0049	CcSEcCtD
Pimozide—Hypotension—Etoposide—muscle cancer	0.000282	0.00489	CcSEcCtD
Pimozide—Dysphagia—Doxorubicin—muscle cancer	0.000276	0.00478	CcSEcCtD
Pimozide—ABCB1—vagina—muscle cancer	0.000274	0.00493	CbGeAlD
Pimozide—Eosinophilia—Doxorubicin—muscle cancer	0.000273	0.00473	CcSEcCtD
Pimozide—Sweating—Methotrexate—muscle cancer	0.000272	0.00471	CcSEcCtD
Pimozide—Somnolence—Etoposide—muscle cancer	0.000269	0.00466	CcSEcCtD
Pimozide—Asthenia—Vincristine—muscle cancer	0.000268	0.00464	CcSEcCtD
Pimozide—Vomiting—Dactinomycin—muscle cancer	0.000265	0.0046	CcSEcCtD
Pimozide—Agranulocytosis—Methotrexate—muscle cancer	0.000265	0.00459	CcSEcCtD
Pimozide—Rash—Dactinomycin—muscle cancer	0.000263	0.00456	CcSEcCtD
Pimozide—Decreased appetite—Etoposide—muscle cancer	0.000263	0.00455	CcSEcCtD
Pimozide—Pancytopenia—Doxorubicin—muscle cancer	0.000262	0.00454	CcSEcCtD
Pimozide—Gastrointestinal disorder—Etoposide—muscle cancer	0.000261	0.00452	CcSEcCtD
Pimozide—Constipation—Etoposide—muscle cancer	0.000258	0.00448	CcSEcCtD
Pimozide—Diarrhoea—Vincristine—muscle cancer	0.000255	0.00442	CcSEcCtD
Pimozide—Pollakiuria—Doxorubicin—muscle cancer	0.000255	0.00441	CcSEcCtD
Pimozide—ABCB1—head—muscle cancer	0.000253	0.00456	CbGeAlD
Pimozide—Weight increased—Doxorubicin—muscle cancer	0.000251	0.00435	CcSEcCtD
Pimozide—Weight decreased—Doxorubicin—muscle cancer	0.000249	0.00432	CcSEcCtD
Pimozide—Nausea—Dactinomycin—muscle cancer	0.000248	0.0043	CcSEcCtD
Pimozide—Dizziness—Vincristine—muscle cancer	0.000247	0.00427	CcSEcCtD
Pimozide—Drowsiness—Doxorubicin—muscle cancer	0.000246	0.00426	CcSEcCtD
Pimozide—Visual impairment—Methotrexate—muscle cancer	0.000245	0.00425	CcSEcCtD
Pimozide—ABCB1—testis—muscle cancer	0.000245	0.0044	CbGeAlD
Pimozide—Urticaria—Etoposide—muscle cancer	0.00024	0.00416	CcSEcCtD
Pimozide—Eye disorder—Methotrexate—muscle cancer	0.000238	0.00413	CcSEcCtD
Pimozide—Vomiting—Vincristine—muscle cancer	0.000237	0.00411	CcSEcCtD
Pimozide—Cardiac disorder—Methotrexate—muscle cancer	0.000236	0.0041	CcSEcCtD
Pimozide—Sweating—Doxorubicin—muscle cancer	0.000236	0.00408	CcSEcCtD
Pimozide—Rash—Vincristine—muscle cancer	0.000235	0.00408	CcSEcCtD
Pimozide—Dermatitis—Vincristine—muscle cancer	0.000235	0.00407	CcSEcCtD
Pimozide—Headache—Vincristine—muscle cancer	0.000234	0.00405	CcSEcCtD
Pimozide—Agranulocytosis—Doxorubicin—muscle cancer	0.000229	0.00397	CcSEcCtD
Pimozide—Mental disorder—Methotrexate—muscle cancer	0.000223	0.00387	CcSEcCtD
Pimozide—Nausea—Vincristine—muscle cancer	0.000221	0.00384	CcSEcCtD
Pimozide—Asthenia—Etoposide—muscle cancer	0.000217	0.00376	CcSEcCtD
Pimozide—Connective tissue disorder—Doxorubicin—muscle cancer	0.000217	0.00376	CcSEcCtD
Pimozide—Pruritus—Etoposide—muscle cancer	0.000214	0.0037	CcSEcCtD
Pimozide—Visual impairment—Doxorubicin—muscle cancer	0.000213	0.00368	CcSEcCtD
Pimozide—Vision blurred—Methotrexate—muscle cancer	0.000209	0.00362	CcSEcCtD
Pimozide—Diarrhoea—Etoposide—muscle cancer	0.000207	0.00358	CcSEcCtD
Pimozide—Eye disorder—Doxorubicin—muscle cancer	0.000206	0.00357	CcSEcCtD
Pimozide—Anaemia—Methotrexate—muscle cancer	0.000205	0.00355	CcSEcCtD
Pimozide—Cardiac disorder—Doxorubicin—muscle cancer	0.000205	0.00355	CcSEcCtD
Pimozide—Dizziness—Etoposide—muscle cancer	0.0002	0.00346	CcSEcCtD
Pimozide—Leukopenia—Methotrexate—muscle cancer	0.000198	0.00344	CcSEcCtD
Pimozide—Mental disorder—Doxorubicin—muscle cancer	0.000193	0.00335	CcSEcCtD
Pimozide—Convulsion—Methotrexate—muscle cancer	0.000192	0.00333	CcSEcCtD
Pimozide—Vomiting—Etoposide—muscle cancer	0.000192	0.00333	CcSEcCtD
Pimozide—Rash—Etoposide—muscle cancer	0.00019	0.0033	CcSEcCtD
Pimozide—Dermatitis—Etoposide—muscle cancer	0.00019	0.0033	CcSEcCtD
Pimozide—Headache—Etoposide—muscle cancer	0.000189	0.00328	CcSEcCtD
Pimozide—Myalgia—Methotrexate—muscle cancer	0.000189	0.00327	CcSEcCtD
Pimozide—Chest pain—Methotrexate—muscle cancer	0.000189	0.00327	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000187	0.00325	CcSEcCtD
Pimozide—Muscle spasms—Doxorubicin—muscle cancer	0.000185	0.0032	CcSEcCtD
Pimozide—Vision blurred—Doxorubicin—muscle cancer	0.000181	0.00314	CcSEcCtD
Pimozide—Nausea—Etoposide—muscle cancer	0.000179	0.00311	CcSEcCtD
Pimozide—Nervous system disorder—Methotrexate—muscle cancer	0.000177	0.00308	CcSEcCtD
Pimozide—Anaemia—Doxorubicin—muscle cancer	0.000177	0.00308	CcSEcCtD
Pimozide—Agitation—Doxorubicin—muscle cancer	0.000176	0.00306	CcSEcCtD
Pimozide—Skin disorder—Methotrexate—muscle cancer	0.000176	0.00305	CcSEcCtD
Pimozide—Hyperhidrosis—Methotrexate—muscle cancer	0.000175	0.00303	CcSEcCtD
Pimozide—Anorexia—Methotrexate—muscle cancer	0.000172	0.00299	CcSEcCtD
Pimozide—Syncope—Doxorubicin—muscle cancer	0.000172	0.00298	CcSEcCtD
Pimozide—Leukopenia—Doxorubicin—muscle cancer	0.000172	0.00298	CcSEcCtD
Pimozide—Palpitations—Doxorubicin—muscle cancer	0.00017	0.00294	CcSEcCtD
Pimozide—Hypotension—Methotrexate—muscle cancer	0.000169	0.00293	CcSEcCtD
Pimozide—Loss of consciousness—Doxorubicin—muscle cancer	0.000169	0.00293	CcSEcCtD
Pimozide—Convulsion—Doxorubicin—muscle cancer	0.000166	0.00288	CcSEcCtD
Pimozide—Hypertension—Doxorubicin—muscle cancer	0.000166	0.00287	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000165	0.00286	CcSEcCtD
Pimozide—Insomnia—Methotrexate—muscle cancer	0.000164	0.00284	CcSEcCtD
Pimozide—Chest pain—Doxorubicin—muscle cancer	0.000163	0.00283	CcSEcCtD
Pimozide—Myalgia—Doxorubicin—muscle cancer	0.000163	0.00283	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000162	0.00281	CcSEcCtD
Pimozide—Somnolence—Methotrexate—muscle cancer	0.000161	0.00279	CcSEcCtD
Pimozide—Dry mouth—Doxorubicin—muscle cancer	0.00016	0.00277	CcSEcCtD
Pimozide—Decreased appetite—Methotrexate—muscle cancer	0.000157	0.00273	CcSEcCtD
Pimozide—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000156	0.00271	CcSEcCtD
Pimozide—Shock—Doxorubicin—muscle cancer	0.000154	0.00267	CcSEcCtD
Pimozide—Nervous system disorder—Doxorubicin—muscle cancer	0.000154	0.00266	CcSEcCtD
Pimozide—Tachycardia—Doxorubicin—muscle cancer	0.000153	0.00265	CcSEcCtD
Pimozide—Skin disorder—Doxorubicin—muscle cancer	0.000152	0.00264	CcSEcCtD
Pimozide—Hyperhidrosis—Doxorubicin—muscle cancer	0.000151	0.00263	CcSEcCtD
Pimozide—Anorexia—Doxorubicin—muscle cancer	0.000149	0.00259	CcSEcCtD
Pimozide—Hypotension—Doxorubicin—muscle cancer	0.000146	0.00254	CcSEcCtD
Pimozide—Urticaria—Methotrexate—muscle cancer	0.000144	0.00249	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000143	0.00247	CcSEcCtD
Pimozide—Insomnia—Doxorubicin—muscle cancer	0.000142	0.00246	CcSEcCtD
Pimozide—Somnolence—Doxorubicin—muscle cancer	0.000139	0.00241	CcSEcCtD
Pimozide—Decreased appetite—Doxorubicin—muscle cancer	0.000136	0.00236	CcSEcCtD
Pimozide—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000135	0.00234	CcSEcCtD
Pimozide—Constipation—Doxorubicin—muscle cancer	0.000134	0.00232	CcSEcCtD
Pimozide—Asthenia—Methotrexate—muscle cancer	0.00013	0.00225	CcSEcCtD
Pimozide—Pruritus—Methotrexate—muscle cancer	0.000128	0.00222	CcSEcCtD
Pimozide—Urticaria—Doxorubicin—muscle cancer	0.000124	0.00216	CcSEcCtD
Pimozide—Diarrhoea—Methotrexate—muscle cancer	0.000124	0.00215	CcSEcCtD
Pimozide—Dizziness—Methotrexate—muscle cancer	0.00012	0.00207	CcSEcCtD
Pimozide—Vomiting—Methotrexate—muscle cancer	0.000115	0.00199	CcSEcCtD
Pimozide—Rash—Methotrexate—muscle cancer	0.000114	0.00198	CcSEcCtD
Pimozide—Dermatitis—Methotrexate—muscle cancer	0.000114	0.00198	CcSEcCtD
Pimozide—Headache—Methotrexate—muscle cancer	0.000113	0.00197	CcSEcCtD
Pimozide—Asthenia—Doxorubicin—muscle cancer	0.000112	0.00195	CcSEcCtD
Pimozide—Pruritus—Doxorubicin—muscle cancer	0.000111	0.00192	CcSEcCtD
Pimozide—Nausea—Methotrexate—muscle cancer	0.000107	0.00186	CcSEcCtD
Pimozide—Diarrhoea—Doxorubicin—muscle cancer	0.000107	0.00186	CcSEcCtD
Pimozide—Dizziness—Doxorubicin—muscle cancer	0.000104	0.0018	CcSEcCtD
Pimozide—Vomiting—Doxorubicin—muscle cancer	9.96e-05	0.00173	CcSEcCtD
Pimozide—Rash—Doxorubicin—muscle cancer	9.88e-05	0.00171	CcSEcCtD
Pimozide—Dermatitis—Doxorubicin—muscle cancer	9.87e-05	0.00171	CcSEcCtD
Pimozide—Headache—Doxorubicin—muscle cancer	9.81e-05	0.0017	CcSEcCtD
Pimozide—Nausea—Doxorubicin—muscle cancer	9.31e-05	0.00161	CcSEcCtD
Pimozide—CALM1—Signaling by NGF—KIT—muscle cancer	7.1e-05	0.000672	CbGpPWpGaD
Pimozide—CALM2—Signaling by NGF—KIT—muscle cancer	7.1e-05	0.000672	CbGpPWpGaD
Pimozide—DRD3—Circadian rythm related genes—TP53—muscle cancer	7.04e-05	0.000666	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—FOXO4—muscle cancer	6.91e-05	0.000654	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—FOXO4—muscle cancer	6.91e-05	0.000654	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—PTCH1—muscle cancer	6.75e-05	0.000639	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—PTCH1—muscle cancer	6.64e-05	0.000629	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—IGF2—muscle cancer	6.63e-05	0.000627	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—PTCH1—muscle cancer	6.63e-05	0.000627	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—PTCH1—muscle cancer	6.52e-05	0.000617	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—CNR1—muscle cancer	6.49e-05	0.000614	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—IGF2—muscle cancer	6.42e-05	0.000607	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—IGF2—muscle cancer	6.42e-05	0.000607	CbGpPWpGaD
Pimozide—CALM3—Immune System—CD34—muscle cancer	6.38e-05	0.000603	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—CNR1—muscle cancer	6.28e-05	0.000594	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—MED12—muscle cancer	6.26e-05	0.000593	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—PTCH1—muscle cancer	6.23e-05	0.000589	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—FH—muscle cancer	6.2e-05	0.000586	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—CNR1—muscle cancer	6.18e-05	0.000584	CbGpPWpGaD
Pimozide—CALM1—Immune System—CD34—muscle cancer	6.17e-05	0.000583	CbGpPWpGaD
Pimozide—CALM2—Immune System—CD34—muscle cancer	6.17e-05	0.000583	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—CNR1—muscle cancer	6.16e-05	0.000583	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—PTCH1—muscle cancer	6.14e-05	0.000581	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	6.12e-05	0.000579	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—CNR1—muscle cancer	6.06e-05	0.000574	CbGpPWpGaD
Pimozide—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	6.05e-05	0.000573	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—FH—muscle cancer	6.05e-05	0.000572	CbGpPWpGaD
Pimozide—CALM3—Neuronal System—MDM2—muscle cancer	5.9e-05	0.000558	CbGpPWpGaD
Pimozide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	5.83e-05	0.000552	CbGpPWpGaD
Pimozide—CALM3—Signaling by NGF—MDM2—muscle cancer	5.78e-05	0.000547	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—ENO2—muscle cancer	5.71e-05	0.00054	CbGpPWpGaD
Pimozide—CALM2—Neuronal System—MDM2—muscle cancer	5.7e-05	0.00054	CbGpPWpGaD
Pimozide—CALM1—Neuronal System—MDM2—muscle cancer	5.7e-05	0.00054	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—CNR1—muscle cancer	5.7e-05	0.000539	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—FH—muscle cancer	5.7e-05	0.000539	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—CNR1—muscle cancer	5.61e-05	0.000531	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—CNR1—muscle cancer	5.6e-05	0.000529	CbGpPWpGaD
Pimozide—CALM2—Signaling by NGF—MDM2—muscle cancer	5.59e-05	0.000529	CbGpPWpGaD
Pimozide—CALM1—Signaling by NGF—MDM2—muscle cancer	5.59e-05	0.000529	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—PTCH1—muscle cancer	5.52e-05	0.000522	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—CNR1—muscle cancer	5.51e-05	0.000521	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—FOXO1—muscle cancer	5.5e-05	0.00052	CbGpPWpGaD
Pimozide—CALM3—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	5.4e-05	0.000511	CbGpPWpGaD
Pimozide—DRD2—Circadian rythm related genes—TP53—muscle cancer	5.39e-05	0.000509	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—FOXO4—muscle cancer	5.36e-05	0.000507	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—PTCH1—muscle cancer	5.34e-05	0.000505	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—PTCH1—muscle cancer	5.34e-05	0.000505	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—FOXO1—muscle cancer	5.32e-05	0.000503	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—FOXO1—muscle cancer	5.32e-05	0.000503	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—FOXO4—muscle cancer	5.28e-05	0.000499	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—FOXO1—muscle cancer	5.28e-05	0.000499	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—PTCH1—muscle cancer	5.26e-05	0.000498	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—CNR1—muscle cancer	5.26e-05	0.000497	CbGpPWpGaD
Pimozide—CALM2—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	5.22e-05	0.000494	CbGpPWpGaD
Pimozide—CALM1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	5.22e-05	0.000494	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—PTCH1—muscle cancer	5.21e-05	0.000493	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—CNR1—muscle cancer	5.18e-05	0.00049	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—FOXO1—muscle cancer	5.1e-05	0.000483	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—FOXO1—muscle cancer	5.1e-05	0.000483	CbGpPWpGaD
Pimozide—CALM3—Disease—ENO2—muscle cancer	4.91e-05	0.000464	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—FH—muscle cancer	4.83e-05	0.000457	CbGpPWpGaD
Pimozide—CALM2—Disease—ENO2—muscle cancer	4.75e-05	0.000449	CbGpPWpGaD
Pimozide—CALM1—Disease—ENO2—muscle cancer	4.75e-05	0.000449	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—CNR1—muscle cancer	4.66e-05	0.00044	CbGpPWpGaD
Pimozide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	4.6e-05	0.000435	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—PTCH1—muscle cancer	4.54e-05	0.00043	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—MED12—muscle cancer	4.54e-05	0.000429	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—MED12—muscle cancer	4.53e-05	0.000428	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—FOXO4—muscle cancer	4.53e-05	0.000428	CbGpPWpGaD
Pimozide—CALM3—Metabolism—MED12—muscle cancer	4.51e-05	0.000427	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—CNR1—muscle cancer	4.5e-05	0.000426	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—CNR1—muscle cancer	4.5e-05	0.000426	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—FOXO4—muscle cancer	4.48e-05	0.000424	CbGpPWpGaD
Pimozide—CALM3—Disease—HMGA1—muscle cancer	4.46e-05	0.000422	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CNR1—muscle cancer	4.44e-05	0.00042	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CNR1—muscle cancer	4.4e-05	0.000416	CbGpPWpGaD
Pimozide—CALM2—Metabolism—MED12—muscle cancer	4.36e-05	0.000413	CbGpPWpGaD
Pimozide—CALM1—Metabolism—MED12—muscle cancer	4.36e-05	0.000413	CbGpPWpGaD
Pimozide—CALM3—Immune System—FOXO4—muscle cancer	4.33e-05	0.00041	CbGpPWpGaD
Pimozide—CALM2—Disease—HMGA1—muscle cancer	4.32e-05	0.000408	CbGpPWpGaD
Pimozide—CALM1—Disease—HMGA1—muscle cancer	4.32e-05	0.000408	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IGF2—muscle cancer	4.3e-05	0.000407	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IGF2—muscle cancer	4.24e-05	0.000401	CbGpPWpGaD
Pimozide—CALM2—Immune System—FOXO4—muscle cancer	4.19e-05	0.000397	CbGpPWpGaD
Pimozide—CALM1—Immune System—FOXO4—muscle cancer	4.19e-05	0.000397	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—KIT—muscle cancer	4.19e-05	0.000396	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—ENO2—muscle cancer	4.14e-05	0.000391	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—ENO2—muscle cancer	4.13e-05	0.000391	CbGpPWpGaD
Pimozide—CALM3—Metabolism—ENO2—muscle cancer	4.11e-05	0.000389	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—KIT—muscle cancer	4.05e-05	0.000383	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—KIT—muscle cancer	4.05e-05	0.000383	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—KIT—muscle cancer	4.02e-05	0.00038	CbGpPWpGaD
Pimozide—CALM3—Disease—FOXO4—muscle cancer	4e-05	0.000379	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PTCH1—muscle cancer	3.99e-05	0.000377	CbGpPWpGaD
Pimozide—CALM2—Metabolism—ENO2—muscle cancer	3.98e-05	0.000376	CbGpPWpGaD
Pimozide—CALM1—Metabolism—ENO2—muscle cancer	3.98e-05	0.000376	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—FOXO1—muscle cancer	3.96e-05	0.000374	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PTCH1—muscle cancer	3.93e-05	0.000371	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PTCH1—muscle cancer	3.92e-05	0.000371	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—FOXO4—muscle cancer	3.91e-05	0.00037	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—FOXO1—muscle cancer	3.9e-05	0.000369	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—KIT—muscle cancer	3.89e-05	0.000368	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—KIT—muscle cancer	3.89e-05	0.000368	CbGpPWpGaD
Pimozide—CALM2—Disease—FOXO4—muscle cancer	3.87e-05	0.000366	CbGpPWpGaD
Pimozide—CALM1—Disease—FOXO4—muscle cancer	3.87e-05	0.000366	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PTCH1—muscle cancer	3.85e-05	0.000365	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CNR1—muscle cancer	3.83e-05	0.000363	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—FH—muscle cancer	3.73e-05	0.000352	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IGF2—muscle cancer	3.63e-05	0.000344	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IGF2—muscle cancer	3.6e-05	0.00034	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—MED12—muscle cancer	3.5e-05	0.000331	CbGpPWpGaD
Pimozide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	3.47e-05	0.000329	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—FOXO4—muscle cancer	3.43e-05	0.000325	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—MED12—muscle cancer	3.42e-05	0.000323	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—FOXO4—muscle cancer	3.38e-05	0.000319	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—FOXO4—muscle cancer	3.37e-05	0.000319	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CNR1—muscle cancer	3.37e-05	0.000319	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—FOXO1—muscle cancer	3.34e-05	0.000316	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—FOXO4—muscle cancer	3.31e-05	0.000314	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CNR1—muscle cancer	3.31e-05	0.000313	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—FOXO1—muscle cancer	3.31e-05	0.000313	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CNR1—muscle cancer	3.31e-05	0.000313	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—MDM2—muscle cancer	3.3e-05	0.000312	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PTCH1—muscle cancer	3.26e-05	0.000308	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CNR1—muscle cancer	3.25e-05	0.000308	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—MED12—muscle cancer	3.22e-05	0.000305	CbGpPWpGaD
Pimozide—CALM3—Immune System—FOXO1—muscle cancer	3.2e-05	0.000303	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ENO2—muscle cancer	3.19e-05	0.000302	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—MDM2—muscle cancer	3.19e-05	0.000302	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—MDM2—muscle cancer	3.19e-05	0.000302	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—MDM2—muscle cancer	3.17e-05	0.0003	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PTCH1—muscle cancer	3.15e-05	0.000298	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PTCH1—muscle cancer	3.15e-05	0.000298	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IGF2—muscle cancer	3.14e-05	0.000297	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ENO2—muscle cancer	3.12e-05	0.000295	CbGpPWpGaD
Pimozide—CALM2—Immune System—FOXO1—muscle cancer	3.1e-05	0.000293	CbGpPWpGaD
Pimozide—CALM1—Immune System—FOXO1—muscle cancer	3.1e-05	0.000293	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—MDM2—muscle cancer	3.06e-05	0.00029	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—MDM2—muscle cancer	3.06e-05	0.00029	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—KIT—muscle cancer	3.01e-05	0.000285	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—KIT—muscle cancer	2.97e-05	0.000281	CbGpPWpGaD
Pimozide—CALM3—Disease—FOXO1—muscle cancer	2.95e-05	0.00028	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ENO2—muscle cancer	2.94e-05	0.000278	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—FOXO1—muscle cancer	2.89e-05	0.000273	CbGpPWpGaD
Pimozide—CALM1—Disease—FOXO1—muscle cancer	2.86e-05	0.00027	CbGpPWpGaD
Pimozide—CALM2—Disease—FOXO1—muscle cancer	2.86e-05	0.00027	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—FOXO4—muscle cancer	2.8e-05	0.000265	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—VEGFA—muscle cancer	2.78e-05	0.000263	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IGF2—muscle cancer	2.75e-05	0.00026	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CNR1—muscle cancer	2.75e-05	0.00026	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—MED12—muscle cancer	2.73e-05	0.000258	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—FOXO4—muscle cancer	2.71e-05	0.000256	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—FOXO4—muscle cancer	2.71e-05	0.000256	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IGF2—muscle cancer	2.71e-05	0.000256	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IGF2—muscle cancer	2.7e-05	0.000256	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—VEGFA—muscle cancer	2.69e-05	0.000255	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—VEGFA—muscle cancer	2.69e-05	0.000255	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CNR1—muscle cancer	2.66e-05	0.000252	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CNR1—muscle cancer	2.66e-05	0.000252	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IGF2—muscle cancer	2.66e-05	0.000252	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—KIT—muscle cancer	2.55e-05	0.000241	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—FOXO1—muscle cancer	2.53e-05	0.00024	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—KIT—muscle cancer	2.52e-05	0.000239	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.5e-05	0.000236	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—FOXO1—muscle cancer	2.49e-05	0.000236	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—FOXO1—muscle cancer	2.49e-05	0.000235	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ENO2—muscle cancer	2.49e-05	0.000235	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—FOXO1—muscle cancer	2.45e-05	0.000232	CbGpPWpGaD
Pimozide—CALM3—Immune System—KIT—muscle cancer	2.44e-05	0.000231	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—MDM2—muscle cancer	2.37e-05	0.000225	CbGpPWpGaD
Pimozide—CALM2—Immune System—KIT—muscle cancer	2.36e-05	0.000223	CbGpPWpGaD
Pimozide—CALM1—Immune System—KIT—muscle cancer	2.36e-05	0.000223	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—MDM2—muscle cancer	2.34e-05	0.000221	CbGpPWpGaD
Pimozide—CALM3—Disease—KIT—muscle cancer	2.25e-05	0.000213	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IGF2—muscle cancer	2.25e-05	0.000213	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—KIT—muscle cancer	2.2e-05	0.000208	CbGpPWpGaD
Pimozide—CALM2—Disease—KIT—muscle cancer	2.18e-05	0.000206	CbGpPWpGaD
Pimozide—CALM1—Disease—KIT—muscle cancer	2.18e-05	0.000206	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IGF2—muscle cancer	2.18e-05	0.000206	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IGF2—muscle cancer	2.18e-05	0.000206	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—MED12—muscle cancer	2.11e-05	0.000199	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—TP53—muscle cancer	2.1e-05	0.000199	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—FOXO1—muscle cancer	2.07e-05	0.000196	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—TP53—muscle cancer	2.03e-05	0.000192	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—TP53—muscle cancer	2.03e-05	0.000192	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MDM2—muscle cancer	2.01e-05	0.00019	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—FOXO1—muscle cancer	2e-05	0.000189	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—FOXO1—muscle cancer	2e-05	0.000189	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—PTGS2—muscle cancer	1.99e-05	0.000188	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MDM2—muscle cancer	1.99e-05	0.000188	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.94e-05	0.000184	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—KIT—muscle cancer	1.93e-05	0.000183	CbGpPWpGaD
Pimozide—CALM3—Immune System—MDM2—muscle cancer	1.92e-05	0.000182	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ENO2—muscle cancer	1.92e-05	0.000182	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—KIT—muscle cancer	1.9e-05	0.00018	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—KIT—muscle cancer	1.9e-05	0.000179	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—KIT—muscle cancer	1.86e-05	0.000176	CbGpPWpGaD
Pimozide—CALM1—Immune System—MDM2—muscle cancer	1.86e-05	0.000176	CbGpPWpGaD
Pimozide—CALM2—Immune System—MDM2—muscle cancer	1.86e-05	0.000176	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—VEGFA—muscle cancer	1.8e-05	0.000171	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—VEGFA—muscle cancer	1.78e-05	0.000168	CbGpPWpGaD
Pimozide—CALM3—Disease—MDM2—muscle cancer	1.77e-05	0.000168	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MDM2—muscle cancer	1.73e-05	0.000164	CbGpPWpGaD
Pimozide—CALM2—Disease—MDM2—muscle cancer	1.72e-05	0.000162	CbGpPWpGaD
Pimozide—CALM1—Disease—MDM2—muscle cancer	1.72e-05	0.000162	CbGpPWpGaD
Pimozide—CALM3—Disease—PTGS2—muscle cancer	1.71e-05	0.000162	CbGpPWpGaD
Pimozide—CALM2—Disease—PTGS2—muscle cancer	1.65e-05	0.000156	CbGpPWpGaD
Pimozide—CALM1—Disease—PTGS2—muscle cancer	1.65e-05	0.000156	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KIT—muscle cancer	1.58e-05	0.000149	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KIT—muscle cancer	1.53e-05	0.000144	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KIT—muscle cancer	1.53e-05	0.000144	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—VEGFA—muscle cancer	1.52e-05	0.000144	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MDM2—muscle cancer	1.52e-05	0.000144	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—VEGFA—muscle cancer	1.51e-05	0.000143	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MDM2—muscle cancer	1.5e-05	0.000142	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MDM2—muscle cancer	1.49e-05	0.000141	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MDM2—muscle cancer	1.47e-05	0.000139	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PTGS2—muscle cancer	1.44e-05	0.000136	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PTGS2—muscle cancer	1.44e-05	0.000136	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PTGS2—muscle cancer	1.43e-05	0.000135	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PTGS2—muscle cancer	1.38e-05	0.000131	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PTGS2—muscle cancer	1.38e-05	0.000131	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TP53—muscle cancer	1.36e-05	0.000129	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TP53—muscle cancer	1.34e-05	0.000127	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—VEGFA—muscle cancer	1.31e-05	0.000124	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MDM2—muscle cancer	1.24e-05	0.000117	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MDM2—muscle cancer	1.2e-05	0.000114	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MDM2—muscle cancer	1.2e-05	0.000114	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—muscle cancer	1.15e-05	0.000109	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—muscle cancer	1.15e-05	0.000109	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—muscle cancer	1.14e-05	0.000108	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—muscle cancer	1.14e-05	0.000107	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—muscle cancer	1.13e-05	0.000107	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—muscle cancer	1.12e-05	0.000106	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTGS2—muscle cancer	1.11e-05	0.000105	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTGS2—muscle cancer	1.08e-05	0.000103	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTGS2—muscle cancer	1.02e-05	9.67e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—muscle cancer	9.94e-06	9.4e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—muscle cancer	9.43e-06	8.92e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—muscle cancer	9.12e-06	8.63e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—muscle cancer	9.12e-06	8.63e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—muscle cancer	8.72e-06	8.25e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTGS2—muscle cancer	8.66e-06	8.19e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—muscle cancer	8.58e-06	8.12e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—muscle cancer	8.56e-06	8.1e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—muscle cancer	8.43e-06	7.97e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—muscle cancer	7.12e-06	6.74e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—muscle cancer	6.89e-06	6.52e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—muscle cancer	6.89e-06	6.52e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTGS2—muscle cancer	6.68e-06	6.32e-05	CbGpPWpGaD
